These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9565123)

  • 21. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
    Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
    J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk group-based management of differentiated thyroid carcinoma.
    Kuriakose MA; Hicks WL; Loree TR; Yee H
    J R Coll Surg Edinb; 2001 Aug; 46(4):216-23. PubMed ID: 11523714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recurrences and metastases in differentiated thyroid cancer].
    Petkov R
    Khirurgiia (Sofiia); 1995; 48(2):8-10. PubMed ID: 8531449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-risk papillary thyroid cancer recurrence in patients treated with total thyroidectomy and adjuvant therapy vs. patients treated with partial thyroidectomy.
    Hurtado-López LM; Melchor-Ruan J; Basurto-Kuba E; Montes de Oca-Durán ER; Pulido-Cejudo A; Athié-Gutiérrez C
    Cir Cir; 2011; 79(2):118-25. PubMed ID: 21631972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Well-differentiated thyroid carcinoma in Hong Kong Chinese patients under 21 years of age: a 35-year experience.
    Lee YM; Lo CY; Lam KY; Wan KY; Tam PK
    J Am Coll Surg; 2002 Jun; 194(6):711-6. PubMed ID: 12081061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.
    Taylor T; Specker B; Robbins J; Sperling M; Ho M; Ain K; Bigos ST; Brierley J; Cooper D; Haugen B; Hay I; Hertzberg V; Klein I; Klein H; Ladenson P; Nishiyama R; Ross D; Sherman S; Maxon HR
    Ann Intern Med; 1998 Oct; 129(8):622-7. PubMed ID: 9786809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of patients with differentiated thyroid carcinoma following initial therapy.
    Jonklaas J; Sarlis NJ; Litofsky D; Ain KB; Bigos ST; Brierley JD; Cooper DS; Haugen BR; Ladenson PW; Magner J; Robbins J; Ross DS; Skarulis M; Maxon HR; Sherman SI
    Thyroid; 2006 Dec; 16(12):1229-42. PubMed ID: 17199433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
    Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
    Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
    Franceschi M; Kusić Z; Franceschi D; Lukinac L; Roncević S
    J Nucl Med; 1996 Mar; 37(3):446-51. PubMed ID: 8772642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk stratification of 282 differentiated thyroid cancers found incidentally in 1369 total thyroidectomies according to the 2015 ATA guidelines; implications for management and treatment.
    Christakis I; Dimas S; Kafetzis ID; Roukounakis N
    Ann R Coll Surg Engl; 2018 May; 100(5):357-365. PubMed ID: 29484944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution.
    Sciuto R; Romano L; Rea S; Marandino F; Sperduti I; Maini CL
    Ann Oncol; 2009 Oct; 20(10):1728-35. PubMed ID: 19773250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
    Yildirim E
    J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Loco-regional persistence and recurrences of operated differentiated thyroid cancers. 22 cases on 589 treated patients from 1964 to 1990, follow-up from 5 to 31 years].
    Proye C; Gontier A; Capuano G; Combemale F; Carnaille B; Decoulx M; Wemeau JL; Lecomte-Houcke M
    Ann Endocrinol (Paris); 1997; 58(3):233-9; discussion 240-1. PubMed ID: 9239247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follicular thyroid cancer in children and adolescents: clinicopathologic features, long-term survival, and risk factors for recurrence.
    Enomoto K; Enomoto Y; Uchino S; Yamashita H; Noguchi S
    Endocr J; 2013; 60(5):629-35. PubMed ID: 23327804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children.
    Jarzab B; Handkiewicz Junak D; Włoch J; Kalemba B; Roskosz J; Kukulska A; Puch Z
    Eur J Nucl Med; 2000 Jul; 27(7):833-41. PubMed ID: 10952495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival of differentiated thyroid carcinoma studied in 500 patients.
    Lerch H; Schober O; Kuwert T; Saur HB
    J Clin Oncol; 1997 May; 15(5):2067-75. PubMed ID: 9164219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current state of the treatment of thyroid cancer].
    Paches AI; Liubaev VL; Shental' VV; Pustynskiĭ IN; Abdullin NA
    Vopr Onkol; 1998; 44(5):562-6. PubMed ID: 9884715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.